Trimedyne Enters Into Letter of Intent With FemSuite, LLC (Marketwire via Yahoo! Finance)
TRIMEDYNE, INC. today announced it has entered into a Letter of Intent with FemSuite, LLC, a privately held company based in San Francisco which develops, manufactures and markets a variety of devices for use in the gynecology field. Under the Letter of Intent, Trimedyne has offered to license seven of its U.S. patents and two U.S. patent applications exclusively to FemSuite for any use in the ...

The Cystic Fibrosis (CF) Market is Poised for Significant Change. Will New Agents Emerge as First-Line Therapies? (Business Wire via Yahoo! Finance)
DUBLIN, Ireland----Research and Markets has announced the addition of Decision Resources, Inc.'s new report "Cystic Fibrosis: Will New Agents Emerge as First-Line Therapies?" to their offering.